-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, Retro Biosciences stepped out of stealth mode and announced the completion of a $180 million financing
Globally, a large amount of medical and health spending is spent on the treatment of age-related diseases, and the reason behind age-related diseases is the aging process itself
The company's initial focus areas include cell reprogramming, plasma-related therapies, and autophagy
The company's co-founders include serial entrepreneur Dr.
References:
[1] Announcing Retro Biosciences.